Article Details

Sorrento Receives FDA Clearance to Proceed With Phase 2 Study for Sti-3031, an Anti-Pd-L1 ...

Retrieved on: 2021-04-27 15:33:45

Tags for this article:

Click the tags to see associated articles and topics

Sorrento Receives FDA Clearance to Proceed With Phase 2 Study for Sti-3031, an Anti-Pd-L1 .... View article details on hiswai:

Excerpt

... of fully human monoclonal antibodies (mAbs) for the treatment of COVID-19 ... A second antibody, Socazolimab, is licensed to Lee's Pharmaceutical ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo